Dr Reddy’s Labs shares slide 6% post Q3 results. Should you buy, sell, or hold?

Dr. Reddy’s Laboratories shares slipped by as much as 6.2% to an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, after the company reported its Q3 FY25 earnings. The pharma major posted a marginal 2% year-on-year (YoY) growth in consolidated net profit, reaching Rs 1,413 crore,…